NeuViz 16 Multi-Slice CT Scanner System PN: 989605858501 a whole body computed tomography X-ray ...
FDA Device Recall #Z-1573-2016 — Class II — March 24, 2016
Recall Summary
| Recall Number | Z-1573-2016 |
| Classification | Class II — Moderate risk |
| Date Initiated | March 24, 2016 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Philips and Neusoft Medical Systems Co., Ltd. |
| Location | Shenyang, N/A |
| Product Type | Devices |
| Quantity | 37 units |
Product Description
NeuViz 16 Multi-Slice CT Scanner System PN: 989605858501 a whole body computed tomography X-ray system featuring a continuously rotating X-ray tube and detector array with multi-slice capability up to 16 slices simultaneously.
Reason for Recall
The following issues are found in NeuViz 16 systems with software version 1.1.4.21425 and version 1.1.4.21426: 1) During the filming operation on MX 16-slice console software, the clipboard used for copying and pasting images is not cleared between patients. If the operator fails to copy the current patient's images before pasting, a previous patient's image may be present in the clipboard and be
Distribution Pattern
NC, OH, NE, SC, TX, LA, PR, MO, FL, CT
Lot / Code Information
Serial Numbers: N16E090002, N16E090003, N16E090007, N16E090008, N16E090010, N16E100023, N16E110023, N16E110026, N16E120016, N16E120023, N16E120052, N16E120053, N16E130012, N16E130038, N16E130045, N16E140008, N16E140007, N16E140012, N16E140017, N16E140020, N16E140029, N16E140056, N16E140057, N16E140058, N16E150004, N16E150014, N16E150013, N16E150015, N16E150025, N16E150024, N16E150027, N16E150038, N16E150039, N16E150040, N16E100017, N16E140030 and N16E140031
Other Recalls from Philips and Neusoft Medical Systems C...
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1165-2013 | Class II | NeuViz 16 Multi-Slice CT Scanner System, Part n... | Mar 4, 2013 |
| Z-1166-2013 | Class II | NeuViz Dual series CT Scanner System, Part n... | Mar 4, 2013 |
| Z-0466-2013 | Class II | NeuViz 16 Multi-Sliced CT Scanner System, part ... | Oct 18, 2012 |
| Z-2083-2012 | Class II | NeuViz 16 Multi-Slice CT Scanner System is a co... | Jun 8, 2012 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.